Fujian Aoxin Biotechnology Group Co., Ltd. announced that it will issue common shares for gross proceeds of CNY 200,000,000 on July 19, 2023. The transaction will include participation from returning investor, Fujian Aonong Biological Technology Group Incorporation Limited. The transaction has been approved at the twenty-seventh meeting of the third board of directors.

The company's registered capital will increase from CNY 250,000,000 to CNY 450,000,000.